Spire Wealth Management’s Bioventus BVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
– Sell
-38,243
Closed -$402K – 2482
2024
Q4
$402K Buy
+38,243
New +$452K 0.01% 625
2022
Q1
– Sell
-715
Closed -$10K – 2560
2021
Q4
$10K Buy
+715
New +$10.2K ﹤0.01% 2366

Other funds holding BVS

Spire Wealth Management's BVS Position: Q1 2025 in Review

Spire Wealth Management sold out of Bioventus (BVS) in Q1 2025, closing a stake of 38,243 shares — an estimated $402K sold.

Spire Wealth Management first reported a position in BVS in Q4 2021 and held it in 2 quarters. The position peaked at $402K in Q4 2024. 144 funds tracked by Wall St. Rank hold BVS as of Q1 2025.

  • Spire Wealth Management reported no remaining Bioventus position as of Q1 2025 after selling out during the quarter.
  • Spire Wealth Management sold 38,243 Bioventus shares in Q1 2025, an estimated $402K.
  • Spire Wealth Management first reported a position in Bioventus in Q4 2021 and held it in 2 quarters.
  • Spire Wealth Management's Bioventus position peaked at $402K in Q4 2024.
  • 144 funds tracked by Wall St. Rank held Bioventus as of Q1 2025.

Based on Spire Wealth Management's 13F filing for Q1 2025, filed 23 Apr 2025.